Low seroconversion rates in CAPD patients compared to hemodialysis patients: Potential advantages for transplant candidates
Gespeichert in:
| Veröffentlicht in: | Peritoneal dialysis international 2002-07, Vol.22 (4), p.520-523 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 523 |
|---|---|
| container_issue | 4 |
| container_start_page | 520 |
| container_title | Peritoneal dialysis international |
| container_volume | 22 |
| creator | AKPOLAT, Tekin DILEK, Melda BOZFAKIOGLU, Semra AKCICEK, Fehmi ATES, Kenan ARINSOY, Turgay YAVUZ, Mahmut UTAS, Cengiz OZENER, Cetin KARAYAYLALI, Ibrahim YILMAZ, Emin ERSOY, Fevzi CAMSARI, Taner ATAMAN, Rezzan |
| description | |
| doi_str_mv | 10.1177/089686080202200414 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72120051</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72120051</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-8231d08c5403a1d9dae0fcf39d97ac544b80c6d03c576f46e2bb84cf99e034d73</originalsourceid><addsrcrecordid>eNplkE1PGzEQhi1UBCHtH-ih8qW9LYw_svZyQ2kLlSKRQzmvHNtbjHbXi8cBof55HCVqDj2N9eqZd6yHkM8MLhlT6gp0U-saNHDgHEAyeUJmTDFdSQHyA5ntgGpHnJMLxCcAwQWoM3LOuOBcczUjf1fxlaJP0cbxxScMcaTJZI80jHR5s_5OJ5ODHzNSG4fJJO9ojvTRD9EF079hwH_ENV3HXB4lp8a9mDGbP6Woi4nmZEac-hJRa0YX3O7ER3LamR79p8Ock4efP34v76rV_e2v5c2qsoI3udJcMAfaLiQIw1zjjIfOdqJxjTIllRsNtnYg7ELVnaw932y0tF3TeBDSKTEn3_a9U4rPW4-5HQJa35fv-LjFVnFW9C1YAfketCkiJt-1UwqDSW8tg3anvP1feVn6cmjfbgbvjisHxwX4egAMWtN3RYUNeOREU1AlxTu0bosC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72120051</pqid></control><display><type>article</type><title>Low seroconversion rates in CAPD patients compared to hemodialysis patients: Potential advantages for transplant candidates</title><source>MEDLINE</source><source>SAGE Complete</source><creator>AKPOLAT, Tekin ; DILEK, Melda ; BOZFAKIOGLU, Semra ; AKCICEK, Fehmi ; ATES, Kenan ; ARINSOY, Turgay ; YAVUZ, Mahmut ; UTAS, Cengiz ; OZENER, Cetin ; KARAYAYLALI, Ibrahim ; YILMAZ, Emin ; ERSOY, Fevzi ; CAMSARI, Taner ; ATAMAN, Rezzan</creator><creatorcontrib>AKPOLAT, Tekin ; DILEK, Melda ; BOZFAKIOGLU, Semra ; AKCICEK, Fehmi ; ATES, Kenan ; ARINSOY, Turgay ; YAVUZ, Mahmut ; UTAS, Cengiz ; OZENER, Cetin ; KARAYAYLALI, Ibrahim ; YILMAZ, Emin ; ERSOY, Fevzi ; CAMSARI, Taner ; ATAMAN, Rezzan ; Turkish Multicenter PD Study Group</creatorcontrib><identifier>ISSN: 0896-8608</identifier><identifier>EISSN: 1718-4304</identifier><identifier>DOI: 10.1177/089686080202200414</identifier><identifier>PMID: 12322827</identifier><language>eng</language><publisher>Milton, ON: Multimed</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Emergency and intensive care: renal failure. Dialysis management ; Female ; Hepatitis C - blood ; Hepatitis C - etiology ; Hepatitis C - immunology ; Hepatitis C Antibodies - blood ; Hepatitis C Antibodies - immunology ; Humans ; Intensive care medicine ; Kidney Failure, Chronic - blood ; Kidney Failure, Chronic - complications ; Kidney Failure, Chronic - therapy ; Kidney Transplantation - adverse effects ; Kidney Transplantation - immunology ; Male ; Medical sciences ; Middle Aged ; Peritoneal Dialysis, Continuous Ambulatory - adverse effects ; Renal Dialysis - adverse effects ; Risk Factors ; Serologic Tests ; Time Factors</subject><ispartof>Peritoneal dialysis international, 2002-07, Vol.22 (4), p.520-523</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-8231d08c5403a1d9dae0fcf39d97ac544b80c6d03c576f46e2bb84cf99e034d73</citedby><cites>FETCH-LOGICAL-c329t-8231d08c5403a1d9dae0fcf39d97ac544b80c6d03c576f46e2bb84cf99e034d73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13912374$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12322827$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AKPOLAT, Tekin</creatorcontrib><creatorcontrib>DILEK, Melda</creatorcontrib><creatorcontrib>BOZFAKIOGLU, Semra</creatorcontrib><creatorcontrib>AKCICEK, Fehmi</creatorcontrib><creatorcontrib>ATES, Kenan</creatorcontrib><creatorcontrib>ARINSOY, Turgay</creatorcontrib><creatorcontrib>YAVUZ, Mahmut</creatorcontrib><creatorcontrib>UTAS, Cengiz</creatorcontrib><creatorcontrib>OZENER, Cetin</creatorcontrib><creatorcontrib>KARAYAYLALI, Ibrahim</creatorcontrib><creatorcontrib>YILMAZ, Emin</creatorcontrib><creatorcontrib>ERSOY, Fevzi</creatorcontrib><creatorcontrib>CAMSARI, Taner</creatorcontrib><creatorcontrib>ATAMAN, Rezzan</creatorcontrib><creatorcontrib>Turkish Multicenter PD Study Group</creatorcontrib><title>Low seroconversion rates in CAPD patients compared to hemodialysis patients: Potential advantages for transplant candidates</title><title>Peritoneal dialysis international</title><addtitle>Perit Dial Int</addtitle><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>Hepatitis C - blood</subject><subject>Hepatitis C - etiology</subject><subject>Hepatitis C - immunology</subject><subject>Hepatitis C Antibodies - blood</subject><subject>Hepatitis C Antibodies - immunology</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Kidney Failure, Chronic - blood</subject><subject>Kidney Failure, Chronic - complications</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Kidney Transplantation - immunology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Peritoneal Dialysis, Continuous Ambulatory - adverse effects</subject><subject>Renal Dialysis - adverse effects</subject><subject>Risk Factors</subject><subject>Serologic Tests</subject><subject>Time Factors</subject><issn>0896-8608</issn><issn>1718-4304</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkE1PGzEQhi1UBCHtH-ih8qW9LYw_svZyQ2kLlSKRQzmvHNtbjHbXi8cBof55HCVqDj2N9eqZd6yHkM8MLhlT6gp0U-saNHDgHEAyeUJmTDFdSQHyA5ntgGpHnJMLxCcAwQWoM3LOuOBcczUjf1fxlaJP0cbxxScMcaTJZI80jHR5s_5OJ5ODHzNSG4fJJO9ojvTRD9EF079hwH_ENV3HXB4lp8a9mDGbP6Woi4nmZEac-hJRa0YX3O7ER3LamR79p8Ock4efP34v76rV_e2v5c2qsoI3udJcMAfaLiQIw1zjjIfOdqJxjTIllRsNtnYg7ELVnaw932y0tF3TeBDSKTEn3_a9U4rPW4-5HQJa35fv-LjFVnFW9C1YAfketCkiJt-1UwqDSW8tg3anvP1feVn6cmjfbgbvjisHxwX4egAMWtN3RYUNeOREU1AlxTu0bosC</recordid><startdate>20020701</startdate><enddate>20020701</enddate><creator>AKPOLAT, Tekin</creator><creator>DILEK, Melda</creator><creator>BOZFAKIOGLU, Semra</creator><creator>AKCICEK, Fehmi</creator><creator>ATES, Kenan</creator><creator>ARINSOY, Turgay</creator><creator>YAVUZ, Mahmut</creator><creator>UTAS, Cengiz</creator><creator>OZENER, Cetin</creator><creator>KARAYAYLALI, Ibrahim</creator><creator>YILMAZ, Emin</creator><creator>ERSOY, Fevzi</creator><creator>CAMSARI, Taner</creator><creator>ATAMAN, Rezzan</creator><general>Multimed</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020701</creationdate><title>Low seroconversion rates in CAPD patients compared to hemodialysis patients: Potential advantages for transplant candidates</title><author>AKPOLAT, Tekin ; DILEK, Melda ; BOZFAKIOGLU, Semra ; AKCICEK, Fehmi ; ATES, Kenan ; ARINSOY, Turgay ; YAVUZ, Mahmut ; UTAS, Cengiz ; OZENER, Cetin ; KARAYAYLALI, Ibrahim ; YILMAZ, Emin ; ERSOY, Fevzi ; CAMSARI, Taner ; ATAMAN, Rezzan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-8231d08c5403a1d9dae0fcf39d97ac544b80c6d03c576f46e2bb84cf99e034d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>Hepatitis C - blood</topic><topic>Hepatitis C - etiology</topic><topic>Hepatitis C - immunology</topic><topic>Hepatitis C Antibodies - blood</topic><topic>Hepatitis C Antibodies - immunology</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Kidney Failure, Chronic - blood</topic><topic>Kidney Failure, Chronic - complications</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Kidney Transplantation - immunology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Peritoneal Dialysis, Continuous Ambulatory - adverse effects</topic><topic>Renal Dialysis - adverse effects</topic><topic>Risk Factors</topic><topic>Serologic Tests</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AKPOLAT, Tekin</creatorcontrib><creatorcontrib>DILEK, Melda</creatorcontrib><creatorcontrib>BOZFAKIOGLU, Semra</creatorcontrib><creatorcontrib>AKCICEK, Fehmi</creatorcontrib><creatorcontrib>ATES, Kenan</creatorcontrib><creatorcontrib>ARINSOY, Turgay</creatorcontrib><creatorcontrib>YAVUZ, Mahmut</creatorcontrib><creatorcontrib>UTAS, Cengiz</creatorcontrib><creatorcontrib>OZENER, Cetin</creatorcontrib><creatorcontrib>KARAYAYLALI, Ibrahim</creatorcontrib><creatorcontrib>YILMAZ, Emin</creatorcontrib><creatorcontrib>ERSOY, Fevzi</creatorcontrib><creatorcontrib>CAMSARI, Taner</creatorcontrib><creatorcontrib>ATAMAN, Rezzan</creatorcontrib><creatorcontrib>Turkish Multicenter PD Study Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Peritoneal dialysis international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AKPOLAT, Tekin</au><au>DILEK, Melda</au><au>BOZFAKIOGLU, Semra</au><au>AKCICEK, Fehmi</au><au>ATES, Kenan</au><au>ARINSOY, Turgay</au><au>YAVUZ, Mahmut</au><au>UTAS, Cengiz</au><au>OZENER, Cetin</au><au>KARAYAYLALI, Ibrahim</au><au>YILMAZ, Emin</au><au>ERSOY, Fevzi</au><au>CAMSARI, Taner</au><au>ATAMAN, Rezzan</au><aucorp>Turkish Multicenter PD Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low seroconversion rates in CAPD patients compared to hemodialysis patients: Potential advantages for transplant candidates</atitle><jtitle>Peritoneal dialysis international</jtitle><addtitle>Perit Dial Int</addtitle><date>2002-07-01</date><risdate>2002</risdate><volume>22</volume><issue>4</issue><spage>520</spage><epage>523</epage><pages>520-523</pages><issn>0896-8608</issn><eissn>1718-4304</eissn><cop>Milton, ON</cop><pub>Multimed</pub><pmid>12322827</pmid><doi>10.1177/089686080202200414</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0896-8608 |
| ispartof | Peritoneal dialysis international, 2002-07, Vol.22 (4), p.520-523 |
| issn | 0896-8608 1718-4304 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72120051 |
| source | MEDLINE; SAGE Complete |
| subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Emergency and intensive care: renal failure. Dialysis management Female Hepatitis C - blood Hepatitis C - etiology Hepatitis C - immunology Hepatitis C Antibodies - blood Hepatitis C Antibodies - immunology Humans Intensive care medicine Kidney Failure, Chronic - blood Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Kidney Transplantation - adverse effects Kidney Transplantation - immunology Male Medical sciences Middle Aged Peritoneal Dialysis, Continuous Ambulatory - adverse effects Renal Dialysis - adverse effects Risk Factors Serologic Tests Time Factors |
| title | Low seroconversion rates in CAPD patients compared to hemodialysis patients: Potential advantages for transplant candidates |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A35%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20seroconversion%20rates%20in%20CAPD%20patients%20compared%20to%20hemodialysis%20patients:%20Potential%20advantages%20for%20transplant%20candidates&rft.jtitle=Peritoneal%20dialysis%20international&rft.au=AKPOLAT,%20Tekin&rft.aucorp=Turkish%20Multicenter%20PD%20Study%20Group&rft.date=2002-07-01&rft.volume=22&rft.issue=4&rft.spage=520&rft.epage=523&rft.pages=520-523&rft.issn=0896-8608&rft.eissn=1718-4304&rft_id=info:doi/10.1177/089686080202200414&rft_dat=%3Cproquest_cross%3E72120051%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72120051&rft_id=info:pmid/12322827&rfr_iscdi=true |